Treatment Of Excessive Menstrual Bleeding Associated With Uterine Fibroids

Patent No. EP2731613 (titled "Treatment Of Excessive Menstrual Bleeding Associated With Uterine Fibroids") was filed by Preglem on Jul 12, 2012. The application was issued on Aug 30, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ACCORD HEALTHCAREMay 30, 2018ACCORD HEALTHCARE
ZENTIVA KSMay 30, 2018HOFFMANN EITLE
GENERICS UKMay 29, 2018TER MEER STEINMEISTER & PARTNER
HELMMay 29, 2018UEXKULL & STOLBERG
HEXALMay 29, 2018MAIWALD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2731613

PREGLEM
Application Number
EP12755904A
Filing Date
Jul 12, 2012
Status
Revoked
Jul 10, 2020
Publication Date
Aug 30, 2017